VIRTUAL Primary Care Update Series

Sports Medicine for the PCP

Feb. 11, 2021 | 12:00 p.m. – 1:00 p.m. (CST)

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Course Description:

This 6 hour virtual course will cover key topics for shoulder rehabilitation.  It will include and overview of clinical evaluation of the shoulder complex followed by classification and breakdown of rotator cuff pathology.  A detailed evidence based presentation of rehabilitation following rotator cuff repair including massive repair will be included.  Finally, an overview of shoulder exercise progression concepts based on EMG and positional study will be covered followed by a presentation of rehabilitation following superior labral repair.  Q & A sessions will be available I the distance (virtual) format to allow for interaction in this course.

Course Objectives: 

Following participation in this course, the participant will be able to:

1)Recognize scapular pathology and utilize special tests to aid in this recognition

2) Understand the scientific principles behind rotator cuff repair rehabilitation

3) Apply therapeutic exercise progressions for rotator cuff and scapular stabilization based on EMG and biomechanical study

4) Understand the role of the superior labrum and surgical and rehabilitation techniques recommended to address labral pathology

Agenda:

8-9:30: Clinical Evaluation  of the Shoulder Complex

9:30-11:00: Rehabilitation following Rotator Cuff Repair

12:00-1:30: Shoulder and Scapular Exercise Progression

1:30-3:00:  Rehabilitation of Superior Labral Injury

Course Instructor: Todd S. Ellenbecker, DPT, MS, SCS, OCS, CSCS

Todd Ellenbecker is a physical therapist who joined Rehab Plus Sports Therapy Scottsdale in August of 2018 after serving as Clinic Director and Director of Clinical Research for Physiotherapy Associates Scottsdale Sports Clinic for 23 years.  He is also  the Vice President of Medical Services for the ATP World Tour.

He received his degree in Physical Therapy from the University of Wisconsin-LaCrosse in 1985 and a master’s degree in Exercise Physiology from Arizona State University in 1989.  He completed his Doctor of Physical Therapy from MGH –Institute of Health Professions in 2006.  In addition, he is certified as a Sports Clinical Specialist, and Orthopaedic Clinical Specialist by the APTA.  He is a Certified Strength and Conditioning Specialist by the NSCA and was awarded their Sports Medicine Professional of the Year in 2003.  He is a certified USPTA tennis teaching master professional, and was Chairman of the USTA National Sport Science Committee for 12 years, serving on the committee for more than 30 years.  In 2007 he received the Ron Peyton award by the Sports Physical Therapy Section and in 2008 was the recipient of Samuel Hardy Educational Merit award from the International Tennis Hall of Fame.  He received the Turner A. Blackburn Hall of Fame/Lifetime Achievement Award from the Sports Physical Therapy Association in 2011.  Todd continues as a member of the Thera-Band Research Advisory Committee (TRAC) since its inception in 1998.

Ellenbecker served as the Chairman of the APTA’s Shoulder Special Interest Group from 1996 to 2002, and is a manuscript reviewer for the American Journal of Sports Medicine, and serves on 3 editorial boards: International Journal of Sports Physical Therapy, Sports Health, and Physical Therapy in Sport. He has conducted, published, and presented research primarily on upper extremity athletes, as well as shoulder and elbow rehabilitation.  His main focus of research has been on musculoskeletal adaptations in elite level tennis players and overhead athletes.  He is the author/editor of 15 books, over 75 book chapters and has published over 55 peer reviewed articles in scientific journals. Ellenbecker lives in Scottsdale Arizona with his wife Gail and is a lifelong tennis player

631

Participants will be awarded 0.6 CEU’s or 6 Contact Hours

PROGRAM CANCELLED – DUE TO COVID-19

Jan. 24-31, 2021

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – Freedom of the Seas
7-night | Southern Caribbean
Cruise Departure: San Juan, Puerto Rico
Ports: Philipsburg, St. Maarten | Basseterre, St. Kitts & Nevis | Oranjestad, Aruba | Kralendijk, Bonaire

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

VIRTUAL Primary Care Update Series

Common Diagnosis Strategies and Treatment Options in Autism

Jan. 14, 2021 | 12:00 p.m. – 1:00 p.m. (CST)

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Time: Thursday, December 10, 2020 6:30-7:30PM MST

Location: Zoom webinar

Webinar  Description:

The goal of this one-hour webinar is to examine the Clinical Practice Guideline to Improve Locomotor Function Following Chronic Stroke, Incomplete Spinal Cord Injury, and Brain Injury (Hornby et al. 2020). The course will focus on the implications of the recommended guidelines as well as the inherent limitations of the guidelines. The webinar will involve a live lecture with a moderated chat.

Learning Objectives:

At the completion of this webinar, the participant will be able to:

1. Describe the recommended clinical practice guidelines to improve locomotor function following chronic central nervous system injury.
2. Describe the limitations of the clinical practice guidelines.
3. Discuss the anticipated outcomes with implementation of the clinical practice guidelines to improve locomotor function.

Instructor Bio: Virginia Little, PT, PhD, is an assistant professor in the Doctor of Physical Therapy program at A.T. Still University. She is a board-certified clinical specialist in neurologic physical therapy through the American Board of Physical Therapy Specialties. She has treated patients with neurologic disorders including stroke, spinal cord injury, and brain injury for over 20 years. Her research interests are focused on walking recovery following stroke through the lens of biomechanical function.

CEU: Participants are awarded .1 CEUs or 1 contact hours at the end of the webinar.

Cost: $35;  $25 for ATSU Alumni and current Clinical Instructors

Registrants will be sent the Zoom meeting ID and password after registering for the webinar.

Sponsored by the A.T. Still Neurologic Physical Therapy Residency Program.

VIRTUAL Primary Care Update

Dec. 3-4, 2020

Dec. 3 | 12:00 p.m. – 4:05 p.m. (CST)

Dec. 4 | 8:30 a.m. – 12:45 p.m. (CST)

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

VIRTUAL Primary Care Update

Dermatology – Non-Melanoma Skin Cancer

Nov. 12, 2020 | 12:00 p.m. – 1:00 p.m. (CST)

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Description:
This course presents essential evidence-based tests and measures used for
examination of neurologic impairments, activity limitations, and
participation restrictions with application to case studies. The focus of the
course is practicing and applying these outcome measures organized
according to International Classification of Functioning, Disability and Health
(ICF) levels.

Objectives:
At completion of this course, the participant will be able to:
• Discuss the choice of outcome measures based on the ICF model,
psychometric properties, and recomendations from the StrokEDGE, TBI EDGE,
and Core Measures CPG of the Academy of Neurologic Physical Therapy
• Demonstrate tests and measures of impairment, activity limitations and
participation measures for individuals with stroke and traumatic brain injury
• Make recommendations for tests and measures for individuals with stroke
and brain injury

Course Instructors: 

Cecelia Glittenberg, PT, PhD; Virginia Little, PT, PhD; Tracy Ellison, PT, DPT

11-12.25 Contact hours earned at course completion

*Course limited to 24 participants

PROGRAM CANCELLED – DUE TO COVID-19

Systematic Approaches to Osteopathic Manipulative Medicine

Oct. 1-3, 2020 Postponed to 2021 Dates TBD

Click MORE for program information and tuition pricing.

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

stance.</p

We apologize but this course has been cancelled.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Kathy Petkovsky, PT, CHT and Cheri Hodges, PT, DPT

Course Description: This course is a lecture and lab course intended for physical therapists working in a general orthopedic clinical practice. The primary instructor has over 30 years of clinical
practice as a CHT. The upper extremity conditions covered includes tendinopathies, peripheral nerve entrapments & fractures in the elbow, wrist, and hand regions.

Course Objectives:

At the conclusion of this course, participants will be able to:

1. Assess the elbow, wrist, and hand regions for common injuries and conditions.

2. Review current best evidence for examination and management of conditions in the region of the elbow, wrist, and hand.

3. Apply improved examination and intervention strategies.

4. Study preparation for the Orthopedic Clinical Specialty Exam (OCS)

CEU: Participants are awarded .7 CEUs or 7 contact hours at the end of the course.

Cost: $225; $175 for ATSU alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Tentatively re-scheduled for August 15, 2020. If you would like a refund for your registration fee please contact Cassie Reynolds at cassiereynolds@atsu.edu

Course Description:

This course focuses on examination and intervention for individuals with vertigo and disequilibrium from vestibular causes using essential, evidence-based tests and measures. The course highlights management of several vestibular pathologies, including a review of anatomy and discussion of examination and interventions for each vestibular disorder. Specific emphasis of the course will be on the management of benign paroxysmal positional vertigo, unilateral peripheral hypofunction, bilateral vestibular hypofunction, and other common vestibular disorders. Case study presentations and hands-on lab components will enhance the learners’ experience. This course is intended for individuals with a general knowledge of vestibular anatomy and physiology, as well as common vestibular disorders.

Course Objectives:

At completion of this course, the participant will be able to:
1. Discuss the differences between normal and abnormal vestibular pathology and how it correlates to clinical examination and interventions.
2. Demonstrate tests and measures that are appropriate for vestibular pathology (peripheral vestibular hypofunction, benign paroxysmal positional vertigo, and bilateral vestibular hypofunction), and apply results to create a comprehensive vestibular rehabilitation program.
3. Refine skills needed to create a patient-specific, evidence based rehabilitation program to help people with vestibular pathology optimize their recovery.

Instructors:

Jamie Kuettel, PT, DPT

Connie Welgarz, PT, DPT

CEU’s: 0.75

COURSE FLYER

PROGRAM CANCELLED – DUE TO COVID-19

Aug. 7-9, 2020 Postponed to Aug. 6-8, 2021 

Click MORE for program information and tuition pricing.

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

We apologize but this course has been cancelled.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Colin Rigney, PT, DPT, OCS, RMSK 

Course Description

• This course will give clinicians knowledge on principles of musculoskeletal ultrasound, including general physics/machine instrumentation, anatomy, pathology and the current role for clinic application as it relates to Physical Therapists.
• This course is designed to give registrants maximal opportunity for practical learning with 4 hours of scanning in the afternoon. Due to the course being one day, the lecture topics will cover areas in the upper extremity most commonly seen in clinical practice

Course Objectives

• Give clinicians an understanding of ultrasound history
• Identify when musculoskeletal sonography is indicated to assist in managing and diagnosing common conditions
• Explain basic physics and instrumentation of ultrasound for optimal viewing potential
• Present information on common uses and limitations using MSK ultrasound
• Review of anatomy for upper extremity scanning
• Present most common pathology with MSK ultrasound
• Give clinicians understanding MSKUS utilization in current best practices
• Perform basic scans of the shoulder, elbow and hand/wrist

** The morning session will cover introduction to musculoskeletal ultrasound imaging and pathology as well as a live demonstration of selected anatomical sites. and introduction and afternoon session will consist of upper extremity scanning and practical application with our expert instructors

CEU: Participants are awarded 0.7 CEUs or 7 contact hours at the end of the course.

Cost: $225 General;  $175 for non ATSU Alumni and Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

CANCELLED – THIS COURSE WILL BE RESCHEDULED FOR FALL 2020

Carrier Based Obturation: Separating Fact from Fallacy

Date:             April 18, 2020 – Saturday

Time:             8:00am – noon

Location:      5855 E. Still Circle, Dental Simulation Clinic

Audience:     Dentist

Format:        Lecture/Hands-On

CE Credit:    4 credits

Tuition:         $250

Course Description: Employing a gutta percha coated instrument for root canal obturation has been an accepted technique for over 30 years, but its popularity is not universal within the ranks of dental professionals. There is still widely held skepticism as to the materials efficacy and appropriateness in certain clinical scenarios, along with adverse experiences with the material. Misinformation, misapplication, and miscalculation of the materials’ capabilities have all served to perpetuate an undeserved reputation. This course will serve to address all concerns about not only the didactic science and research of carrier-based obturation, but also the correct protocols for successful clinical placement. Following a lecture component, participants will practice using size verifiers, gutta core ovens and gutta core obturators on gutta core prepared blocks.

Learning Objectives:

At the conclusion of this presentation, participants will be able to:

1. Discuss and critique the existing literature base as to the validity of the results and conclusions presented.
2. Explain the correct protocols for canal preparation and carrier size selection.
3. Describe the diagnosis and placement of the materials in anatomically challenging scenarios such as bifurcated, elongated and overly broad canal spaces.

Meet the Presenter: 

Stephen P. Niemczyk received his DMD degree from the University Of Pennsylvania School Of Dental Medicine in 1982 and his postgraduate Endodontic certificate in 1984. Since 1995, Dr. Niemczyk has been the Director of Endodontic Microsurgery at Albert Einstein Medical Center in Philadelphia and was named Assistant Post Graduate Director in 2018. Dr. Niemczyk has lectured extensively in the U.S. and internationally, and authored numerous papers and book chapters. He is a member of the Scientific Advisory Board for the Journal of Endodontics and the Journal of Oral and Maxillofacial Surgery, Medicine and Pathology. Dr. Niemczyk is a Diplomate of the American Board of Endodontics, and maintains a full time practice limited to Endodontics in Drexel Hill, PA

Register below under “Choose Tuition Type”

Full course details and day of event information available here.

Dr. Niemczyk’s honorarium is provided by Dentsply Sirona.

A.T. Still University Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

CANCELLED – COURSE WILL BE RESCHEDULED FOR FALL 2020

The Science of Whitening and Make the Recommendation: Toothpaste as Treatment

Date:               March 28, 2020 – Saturday

Time:               8:30am – 11:30am

Location:         5850 E. Still Circle, Saguaro Rm.

Audience:        All Dental Professionals

Format:           Lecture

CE Credit:       2.5 credits

Tuition:           $65

TWO COURSES, ONE HALF DAY!

The Science of Whitening

In the first of this 2-part course, we will discuss a predictable, efficient, and state-of-the-art whitening system that uses advanced ionic technology to transform the whitening experience for both dental practitioner and patient. We will look at the differences between whitening and bleaching products and explore strategies for patient discussion regarding whitening procedures and managing treatment expectations.

Learning Objectives:
•       Explain how tooth-whitening technology works.
•       Describe indications for home and professional tooth whitening options.
•       Effective conversation to discuss tooth whitening and expectations with patients.
•       Make clinical decisions about patient selection for successful tooth whitening.
•       Develop effective tooth whitening messages and marketing strategies.

 Make the Recommendation: Toothpaste as Treatment

In this session, we will explore the formulation and action of toothpastes. Discussion regarding both active and inactive ingredients will enable the dental professional to understand how and why each product works and how they differ from one another. Therapeutic benefits, mechanisms of action, and assist the dental professional with assessing the needs of today’s complex patients and providing them with an appropriate toothpaste recommendation.

Learning Objectives:

• Explain the principle therapeutic outcomes of various toothpaste formulations.
• Describe how fluoride is assimilated into the apatite crystal of enamel.
• Discuss reduction of biofilm and gingivitis via toothpaste.
• Describe management of dentin hypersensitivity with potassium nitrate.
• Determine the appropriate dentifrice based upon individual patient need.

 Meet the Presenter:

Linda D’Amico, RDH, BS has been in the dental profession for 25+ years, first as a clinical dental hygienist and then as a sales representative. She has spent the past 10 years as an Oral Care Consultant with Colgate and enjoys sharing what she has learned with other dental professionals. Linda has provided continuing education to a wide variety of audiences including dental and allied dental students, dental study groups, and organize dentistry groups.

Register below under “Choose Tuition Type”

DAY OF COURSE DETAILS AVAILABLE HERE

This course is sponsored in part by an unrestricted educational grant from Colgate.

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Arizona School of Dentistry & Oral Health and Colgate.

Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Arizona School of Dentistry & Oral Health designates this activity for 2.5 continuing education credits.

Primary Care Update

Mar. 5-7, 2020

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.